The color of fat and its central role in the development and progression of metabolic diseases

Detalhes bibliográficos
Autor(a) principal: Gaggini, Melania
Data de Publicação: 2017
Outros Autores: Carli, Fabrizia, Gastaldelli, Amalia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/95081
https://doi.org/10.1515/hmbci-2017-0060
Resumo: Excess caloric intake does not always translate to an expansion of the subcutaneous adipose tissue (SAT) and increase in fat mass. It is now recognized that adipocyte type (white, WAT, or brown, BAT), size (large vs. small) and metabolism are important factors for the development of cardiometabolic diseases. When the subcutaneous adipose tissue is not able to expand in response to increased energy intake the excess substrate is stored as visceral adipose tissue or as ectopic fat in tissues as muscle, liver and pancreas. Moreover, adipocytes become dysfunctional (adiposopathy, or sick fat), adipokines secretion is increased, fat accumulates in ectopic sites like muscle and liver and alters insulin signaling, increasing the demand for insulin secretion. Thus, there are some subjects that despite having normal weight have the metabolic characteristics of the obese (NWMO), while some obese expand their SAT and remain metabolically healthy (MHO). In this paper we have reviewed the recent findings that relate the metabolism of adipose tissue and its composition to metabolic diseases. In particular, we have discussed the possible role of dysfunctional adipocytes and adipose tissue resistance to the antilipolytic effect of insulin on the development of impaired glucose metabolism. Finally we have reviewed the possible role of BAT vs. WAT in the alteration of lipid and glucose metabolism and the recent studies that have tried to stimulate browning in human adipose tissue.
id RCAP_73c168615b466d02d6ae36c5fb9ba25d
oai_identifier_str oai:estudogeral.uc.pt:10316/95081
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The color of fat and its central role in the development and progression of metabolic diseasesNAFLD; brown adipose tissue; insulin resistance; lipid metabolismAdipocytesAdipose TissueAdipose Tissue, BrownAdipose Tissue, WhiteDisease ProgressionGlucoseHumansInsulinInsulin ResistanceInsulin-Secreting CellsLipid MetabolismLipolysisMetabolic DiseasesDisease SusceptibilityExcess caloric intake does not always translate to an expansion of the subcutaneous adipose tissue (SAT) and increase in fat mass. It is now recognized that adipocyte type (white, WAT, or brown, BAT), size (large vs. small) and metabolism are important factors for the development of cardiometabolic diseases. When the subcutaneous adipose tissue is not able to expand in response to increased energy intake the excess substrate is stored as visceral adipose tissue or as ectopic fat in tissues as muscle, liver and pancreas. Moreover, adipocytes become dysfunctional (adiposopathy, or sick fat), adipokines secretion is increased, fat accumulates in ectopic sites like muscle and liver and alters insulin signaling, increasing the demand for insulin secretion. Thus, there are some subjects that despite having normal weight have the metabolic characteristics of the obese (NWMO), while some obese expand their SAT and remain metabolically healthy (MHO). In this paper we have reviewed the recent findings that relate the metabolism of adipose tissue and its composition to metabolic diseases. In particular, we have discussed the possible role of dysfunctional adipocytes and adipose tissue resistance to the antilipolytic effect of insulin on the development of impaired glucose metabolism. Finally we have reviewed the possible role of BAT vs. WAT in the alteration of lipid and glucose metabolism and the recent studies that have tried to stimulate browning in human adipose tissue.2017-09-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/95081http://hdl.handle.net/10316/95081https://doi.org/10.1515/hmbci-2017-0060eng1868-1891https://www.degruyter.com/document/doi/10.1515/hmbci-2017-0060/htmlGaggini, MelaniaCarli, FabriziaGastaldelli, Amaliainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2021-12-12T06:34:58Zoai:estudogeral.uc.pt:10316/95081Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:13:39.891366Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The color of fat and its central role in the development and progression of metabolic diseases
title The color of fat and its central role in the development and progression of metabolic diseases
spellingShingle The color of fat and its central role in the development and progression of metabolic diseases
Gaggini, Melania
NAFLD; brown adipose tissue; insulin resistance; lipid metabolism
Adipocytes
Adipose Tissue
Adipose Tissue, Brown
Adipose Tissue, White
Disease Progression
Glucose
Humans
Insulin
Insulin Resistance
Insulin-Secreting Cells
Lipid Metabolism
Lipolysis
Metabolic Diseases
Disease Susceptibility
title_short The color of fat and its central role in the development and progression of metabolic diseases
title_full The color of fat and its central role in the development and progression of metabolic diseases
title_fullStr The color of fat and its central role in the development and progression of metabolic diseases
title_full_unstemmed The color of fat and its central role in the development and progression of metabolic diseases
title_sort The color of fat and its central role in the development and progression of metabolic diseases
author Gaggini, Melania
author_facet Gaggini, Melania
Carli, Fabrizia
Gastaldelli, Amalia
author_role author
author2 Carli, Fabrizia
Gastaldelli, Amalia
author2_role author
author
dc.contributor.author.fl_str_mv Gaggini, Melania
Carli, Fabrizia
Gastaldelli, Amalia
dc.subject.por.fl_str_mv NAFLD; brown adipose tissue; insulin resistance; lipid metabolism
Adipocytes
Adipose Tissue
Adipose Tissue, Brown
Adipose Tissue, White
Disease Progression
Glucose
Humans
Insulin
Insulin Resistance
Insulin-Secreting Cells
Lipid Metabolism
Lipolysis
Metabolic Diseases
Disease Susceptibility
topic NAFLD; brown adipose tissue; insulin resistance; lipid metabolism
Adipocytes
Adipose Tissue
Adipose Tissue, Brown
Adipose Tissue, White
Disease Progression
Glucose
Humans
Insulin
Insulin Resistance
Insulin-Secreting Cells
Lipid Metabolism
Lipolysis
Metabolic Diseases
Disease Susceptibility
description Excess caloric intake does not always translate to an expansion of the subcutaneous adipose tissue (SAT) and increase in fat mass. It is now recognized that adipocyte type (white, WAT, or brown, BAT), size (large vs. small) and metabolism are important factors for the development of cardiometabolic diseases. When the subcutaneous adipose tissue is not able to expand in response to increased energy intake the excess substrate is stored as visceral adipose tissue or as ectopic fat in tissues as muscle, liver and pancreas. Moreover, adipocytes become dysfunctional (adiposopathy, or sick fat), adipokines secretion is increased, fat accumulates in ectopic sites like muscle and liver and alters insulin signaling, increasing the demand for insulin secretion. Thus, there are some subjects that despite having normal weight have the metabolic characteristics of the obese (NWMO), while some obese expand their SAT and remain metabolically healthy (MHO). In this paper we have reviewed the recent findings that relate the metabolism of adipose tissue and its composition to metabolic diseases. In particular, we have discussed the possible role of dysfunctional adipocytes and adipose tissue resistance to the antilipolytic effect of insulin on the development of impaired glucose metabolism. Finally we have reviewed the possible role of BAT vs. WAT in the alteration of lipid and glucose metabolism and the recent studies that have tried to stimulate browning in human adipose tissue.
publishDate 2017
dc.date.none.fl_str_mv 2017-09-25
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/95081
http://hdl.handle.net/10316/95081
https://doi.org/10.1515/hmbci-2017-0060
url http://hdl.handle.net/10316/95081
https://doi.org/10.1515/hmbci-2017-0060
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1868-1891
https://www.degruyter.com/document/doi/10.1515/hmbci-2017-0060/html
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134032323149824